- June 30, 2025
Topic/Product:
Alzheimer's, Neurology
Abstract
Check out the latest coverage on Alzforum, spotlighting the NULISA™ platform and its potential to redefine diagnostics in Alzheimer’s and other neurodegenerative diseases.
From detecting attomolar concentrations of key biomarkers to streamlining multi-target analysis from small CSF and plasma volumes, NULISA is setting a new standard in fluid proteomics.
